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High magnetization aqueous ferrofluid: A simple one-pot synthesis
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1Department of Chemistry, Virginia Commonwealth University, Richmond, Virginia 23284, USA
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A one-step polyol method was utilized to prepare a stable aqueous iron/iron oxide ferrofluid. The
dried powders were characterized by x-ray diffraction, electron microscopy, x-ray absorption
spectroscopy, and vibrating sample magnetometry for the determination of phase, morphology, and
magnetic properties. To show its potential for imaging applications, the ferrofluid was also
investigated as a magnetic resonance imaging contrast agent. © 2010 American Institute of Physics.
doi:10.1063/1.3357342
Stable colloidal suspensions of magnetic nanoparticles
have many appealing qualities that have attracted them to
areas of industry, biomedical engineering, physics, and
chemistry. Many ferrofluids are used commercially as heat
transfer fluids for dampeners in loud speakers, in electronic
devices as a form of liquid seals for drive shafts in hard
disks, and in medicine as contrast agents for magnetic reso-
nance imaging MRI due to their T1 and greater T2
enhancement.1–4 There are two main types of stabilizers for
dispersing magnetic nanoparticles such as: surfactant/
polymer stabilized nanoparticles and ionically stabilized
nanoparticles. These stabilizers allow for the formation of
colloidal metal and metal oxide nanoparticles by various
types of chemical and physical interactions. For polar sol-
vents, tetramethylammonium hydroxide is commonly used
as an ionic stabilizer: the hydroxyl group forms at the nano-
particles surface, providing a negatively charged surface
layer. The positively charged tetramethylammonium cation
NCH34
+ forms a diffuse shell in which neighboring par-
ticles will encounter electrostatic repulsion.5–15 For nonpolar
solvent based ferrofluids, surfactants, or polymers that attach
to nanoparticles, such as oleic acid, impose steric effects on
the neighboring nanoparticles. The hydrocarbon has a polar
head that has an affinity for the nanoparticle; the tail of the
surfactant prevents the agglomeration of neighboring
nanoparticles.16 In each case, there are stringent rules which
must be met in order to achieve effective stabilization. These
rules affecting colloidal stability include parameters such as
an optimum size range of the nanoparticles, viscosity of the
carrier liquid, length of the surfactant, temperature, and mag-
netic field strength. Various techniques have been shown to
produce magnetic nanoparticles such as: wet grinding, copre-
cipitation, microemulsion, and aqueous reduction in metal
salts.17–23 After the synthesis of the nanoparticles, additional
steps are typically required to coat them with the appropriate
stabilizer. In most cases, where the goal is an aqueous fer-
rofluid, the resulting nanoparticle is strictly an iron oxide.
This work shows enhanced magnetic properties by forming
aqueous stabilized metal/oxide core/shell nanoparticles. The
oxide shell forms a passivation layer preventing further
oxidation.24
This work presents an alternative method that provides
an easier synthetic route and allows for the formation of
metal/oxide composite nanoparticles. A modified polyol pro-
cess is implemented, which allows for more controllable par-
ticle morphology along with an overall easier synthetic route.
The use of a modified polyol process enabled the liquid
polyol to act not only as a solvent but as a mild reducing
agent. When coupled with a base, the polyol serves as the
perfect medium for reduction in metal salt precursors, while
also forming a stabilizing layer on the nanoparticle
surface.25–29 This ferrofluid was also investigated in vitro by
magnetic resonance relaxivity measurements and in vivo for
its application in MRI.
The synthesis of Fe /FeOx nanoparticles was carried out
under ambient conditions using a modified polyol method.
First, two separate solutions were prepared, solution 1 and
solution 2. Solution 1 contained 0.25 M ironII chloride
tetrahydrate and 1,2 propanediol in a 500-ml round bottom
flask and was heated to refluxing conditions for 30 min. So-
lution 2 containing 5.2 M NaOH and 1,2 propanediol was
heated simultaneously at 100 °C with magnetic stirring. Hot
solution 2 was subsequently added to solution 1 and heating
was continued to refluxing conditions for one hour. The so-
lution underwent a color change from dark orange, gray, and
then finally jet black 20 min post addition. After 1 h the
solution was allowed to cool to room temperature and then
quenched by the addition of methanol. Throughout the reac-
tion the particles did not seem to stick to the magnetic stirrer.
The particles were washed with methanol several times and
magnetically separated using a rare earth magnet. To prepare
an aqueous ferrofluid, the particles were added to a vial with
deionized water and sonicated to help the dispersion. The
particles are stable in the aqueous media for over one year
without visual degradation.
The nanoparticle morphology was confirmed by trans-
mission electron microscopy TEM Fig. 1, which revealed
relative size uniformity with an average diameter of 15
2.5 nm; the sizes are consistent with dynamic light scat-
tering DLS results. X-ray powder diffraction Fig. 2 shows
a mixed phase system with a face centered cubic magnetite
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and a body centered cubic iron. A linear combination fit to
x-ray absorption near edge structure XANES data deter-
mined a composition of 20% metal and 80% oxide, which
was also corroborated by Rietveld refinement on the x-ray
diffraction XRD pattern yielding the same 20/80 ratio. Fig-
ure 3 shows the XANES spectra for the ferrofluid material,
metallic iron foil and an iron oxide standard. Room tempera-
ture vibrating sample magnetometry revealed a saturation
magnetization of 100 emu/g Fig. 4. The saturation magne-
tization Ms was obtained from a magnetization versus 1/H
plot and extrapolating to the point where 1/H is equal to
zero. The values for bulk Fe and Fe3O4 are 220 emu/g and
80–120 emu/g, respectively. This value in magnetization for
nanoparticles containing both iron and iron oxide is expected
for the percentages of each component in this mixed phase
system.
The nanoparticles also have a surfactant-type coating
which will affect the magnetic characteristics of the nanopar-
ticles, as well as act as the colloidal stabilizing agent. Ther-
mal analysis of the dried particles reveals a 20% weight drop
that correlates with an organic decomposition at 195 °C. The
progressive heating of sodium hydroxide in the polyol not
only reduces the Fe2+ to produce the nanoparticles but also
forms a solution that plays an important role in the overall
reaction dynamics. It is hypothesized that a sodium
glycolate-type structure or 1,2 propanediol is adsorbed onto
the surface of the particles allowing for in situ water stabili-
zation. Further surface characterization will be needed to dis-
tinguish between the two possibilities. It is this structure
formed around the nanoparticle that gives both the colloidal
stability and aids in the resistance to oxidation of the iron
metal.
The MRI/spectroscopic experiments were performed on
a 2.4 T/40 cm bore MR system Biospec/Bruker. Spectro-
scopic T1 and T2 1H relaxation measurements of the aqueous
ferrofluid were conducted using an inversion recovery se-
quence with eight inversion times and repetition times TR
at least five times the expected T1 value. For the T2 measure-
ments, a multispin-echo CPMG sequence was employed
with several echo times and TR values at least five times the
expected T1. The relaxation times were computed from least-
squares fitting of the exponentially varying signals using
analysis routines available at the MR system. Relaxivities
were extracted from graphs of relaxation rates 1 /T1 and
1 /T2 versus concentration. The r1 and r2 relaxivities were
found to be 8.6 and 382 s−1 mM−1. These values should be
compared to those reported for the commercial contrast
agent Feridex, which are 12.3 and 191 s−1 mM−1.30
The in vivo investigation was performed by intratumoral
infusion of the aqueous ferrofluid via convection enhanced
delivery31–33 into a tumor bearing rat, 13 days post T9 tumor
cell implantation. The aqueous ferrofluid was infused at
pH 7.5, an iron concentration of 0.34 mM, and a rate of
0.2 l /min for a total volume of 18 L infused. The
T2-weighted images in Fig. 5 were acquired during the infu-
sion and up to six days post. The dark contrast due to the
ferrofluid is clearly seen in the center of the tumor during the
infusion. Then 6 days post infusion, some of the ferrofluid
FIG. 2. XRD pattern showing a two-phase system of iron oxide and -iron.
FIG. 3. XANES spectra for the ferrofluid material, and iron foil and iron
oxide standards.
FIG. 4. Room temperature vibrating-sample magnetometer data plotted as
magnetization electromagnetic unit per gram vs applied field oersted.
FIG. 1. TEM image of magnetite/-Fe particles prepared by the polyol
process in 1,2 propanediol. The TEM shows that the particles size distribu-
tion is relatively monodispersed.
09B304-2 Carroll et al. J. Appl. Phys. 107, 09B304 2010
 [This article is copyrighted as indicated in the article. Reuse of AIP content is subject to the terms at: http://scitation.aip.org/termsconditions. Downloaded to ] IP:
128.172.48.59 On: Fri, 30 Oct 2015 17:06:43
has pushed to the periphery, thereby more clearly defining
the edge of the tumor.
In conclusion, an aqueous ferrofluid containing mono-
disperse Fe /FeOx nanoparticles were produced using a modi-
fied one-pot polyol process. Controlling the reduction in the
iron cations, along with the in situ stabilization results in
particles with an enhanced magnetic moment over solely
iron oxide based ferrofluids due to the incorporation of me-
tallic iron and iron oxide phases in the nanoparticles. These
ferrofluids have many promising aspects in biological appli-
cations and if linked with a biomolecule, could serve as
promising magnetic carriers/labels for efficient biosepara-
tion, drug delivery, and diagnostic applications.
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FIG. 5. T2W images of a tumor-bearing rat infused with aqueous ferrofluid
0.34 mM iron concentration, 18 l at different time points. The infusate
appears dark within the implanted T9 tumor right side of the tumor. Note
that at six-days post infusion, some of the iron/iron oxide particles have
migrated in the tumor periphery dark ring.
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